JP2023505841A5 - - Google Patents

Info

Publication number
JP2023505841A5
JP2023505841A5 JP2022535243A JP2022535243A JP2023505841A5 JP 2023505841 A5 JP2023505841 A5 JP 2023505841A5 JP 2022535243 A JP2022535243 A JP 2022535243A JP 2022535243 A JP2022535243 A JP 2022535243A JP 2023505841 A5 JP2023505841 A5 JP 2023505841A5
Authority
JP
Japan
Prior art keywords
approximately
ophthalmic composition
composition according
buffering agent
muscarinic antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022535243A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023505841A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/065149 external-priority patent/WO2021126874A1/en
Publication of JP2023505841A publication Critical patent/JP2023505841A/ja
Publication of JP2023505841A5 publication Critical patent/JP2023505841A5/ja
Priority to JP2025269821A priority Critical patent/JP2026067867A/ja
Pending legal-status Critical Current

Links

JP2022535243A 2019-12-16 2020-12-15 Ｄ２ｏを含む眼科用組成物 Pending JP2023505841A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025269821A JP2026067867A (ja) 2019-12-16 2025-12-19 Ｄ２ｏを含む眼科用組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962948761P 2019-12-16 2019-12-16
US62/948,761 2019-12-16
US202063080617P 2020-09-18 2020-09-18
US63/080,617 2020-09-18
PCT/US2020/065149 WO2021126874A1 (en) 2019-12-16 2020-12-15 Ophthalmic compositions comprising d2o

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025269821A Division JP2026067867A (ja) 2019-12-16 2025-12-19 Ｄ２ｏを含む眼科用組成物

Publications (2)

Publication Number Publication Date
JP2023505841A JP2023505841A (ja) 2023-02-13
JP2023505841A5 true JP2023505841A5 (https=) 2023-12-25

Family

ID=76478280

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022535243A Pending JP2023505841A (ja) 2019-12-16 2020-12-15 Ｄ２ｏを含む眼科用組成物
JP2025269821A Pending JP2026067867A (ja) 2019-12-16 2025-12-19 Ｄ２ｏを含む眼科用組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025269821A Pending JP2026067867A (ja) 2019-12-16 2025-12-19 Ｄ２ｏを含む眼科用組成物

Country Status (9)

Country Link
US (1) US20230041788A1 (https=)
EP (1) EP4076469A4 (https=)
JP (2) JP2023505841A (https=)
KR (1) KR20220114606A (https=)
CN (1) CN115279378A (https=)
AU (1) AU2020404934A1 (https=)
CA (1) CA3164235A1 (https=)
IL (1) IL293859A (https=)
WO (1) WO2021126874A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
EP3302426A4 (en) 2015-05-29 2018-12-05 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
CN114224830A (zh) * 2021-12-24 2022-03-25 辰欣药业股份有限公司 一种单剂量无抑菌剂的眼用制剂及其制备方法
TW202525288A (zh) * 2023-10-26 2025-07-01 英商庫博光學國際有限公司 液體組合物
WO2025212792A1 (en) * 2024-04-03 2025-10-09 Sydnexis, Inc. Methods and compositions for increasing pupil dilation
WO2026038024A1 (en) * 2024-08-13 2026-02-19 Coopervision International Limited Liquid composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
CA2374003C (en) * 1999-05-17 2008-02-12 Aesgen, Inc. Improved cellular uptake of bioactive agents
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
US9421199B2 (en) * 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US10251875B2 (en) * 2017-05-11 2019-04-09 Nevakar Inc. Atropine pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP2023505841A5 (https=)
JP2022062045A5 (https=)
US4370325A (en) Pharmaceutical compositions and method of treatment
JP2022075813A (ja) ジクアホソル含有点眼液
JP2021185154A5 (https=)
US5948390A (en) Stable zinc/citrate/CPC oral rinse formulations
US8691802B2 (en) Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative
HRP20220972T1 (hr) Oftalmološki pripravci koji sadrže muskarinski antagonist i deuteriranu vodu
RU2013129222A (ru) Глазные композиции, содержащие мукоадгезивные полисахариды, способные стимулировать восстановление эпителия роговицы
JP2008540532A5 (https=)
JPWO1996019211A1 (ja) リポソーム点眼液
ES2283535T3 (es) Producto para el cuidado de lentes que contiene dexpantenol.
US4642234A (en) Disinfection of contact lenses
Waisel The Effect of Ca on the Uptake of Monovalent Ions by Excised Barley Roots.
JP7170436B2 (ja) 水溶性高分子を含む点眼剤
EP0048023A2 (en) Composition for treating and preventing irritation of the eyes
JP4757970B2 (ja) 点眼剤組成物
JPH0261015B2 (https=)
JP2001261552A (ja) 点眼液用保存剤
US7265117B2 (en) Topical brimonidine tartrate formulations that lack chlorine dioxide
JP2005514428A5 (https=)
EP2800573B1 (en) Ophthalmic composition
JP4880808B2 (ja) 人工涙液型点眼剤組成物
TWI911333B (zh) 洗眼用組成物
JP7749316B2 (ja) 洗眼用組成物